Ningxia Tairui Pharmaceutical Co Ltd (Tairui Pharma below)   is an export-oriented national key high-tech enterprise with AAA credit rating, owning a State-level Enterprise Technical Center and Engineering  Laboratory, nearly 3,500 employees, area coverage of over 400 hectares and total assets of nearly RMB5 billion.

Tairui Pharma is mainly engaged in R&D, production and marketing of veterinary APIs and formulations. Leading products include:- Tylosin (Base/Tartrate/ Phosphate), Tilmicosin(phosphate) and Tiamulin Fumarate. Tairui Pharma is proud to declare itself as the largest producer of Tylosin in the world. “Tairui” has been titled as China Famous Brand in 2010. Over 70% of its products have been exported to more than 80 countries and areas worldwide. Since 2011,Tairui entered a new area by starting the production of Erythromycin Thiocyanate with 1000mt annual capacity at its current site and 3000mt capacity at its subsidiary-Ningxia Taipingyang Bio-tech Co., Ltd. All facilities can meet the requirements of current GMP guidelines and have been successfully approved by customers from the Netherlands, Germany, Switzerland, Australia, India, etc.

As a China Top 50 Veterinary Pharmaceutical Enterprise and China Top 10 Veterinary API Enterprise, Tairui has always emphasized on developing and introducing new technologies and products in its National-Grade R&D Center, state-of-the-art facilities and well-equipped laboratory so as to meet the growing and changing demands from customers both at home and abroad.

Following the motto of "Create social wealth, Serve healthcare industry" and undertaking the responsibility of further developing pharmaceutical industry, Tairui Pharma will always strive to build itself into a world-class API production base and accomplish the ambitious mission of “Guarding life, Sharing health”.

Sub-event: CPWW18
Zone: API
Exhibitor categories

Contact details

F20, Dahangjiye Building
NO.33 Rendabeilu